1 |
Balma M, Liberini V, Racca M, Laudicella R, Bauckneht M, Buschiazzo A, Nicolotti DG, Peano S, Bianchi A, Albano G, Quartuccio N, Abgral R, Morbelli SD, D'Alessandria C, Terreno E, Huellner MW, Papaleo A, Deandreis D. Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review. Front Med (Lausanne) 2022;9:881551. [PMID: 35492341 DOI: 10.3389/fmed.2022.881551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
2 |
Barahona D, Chong G, Sola J. Metástasis óseas de carcinoma de mama lobulillar detectadas mediante PET/TC con 68Ga-DOTA-TATE realizada por un tumor neuroendocrino intestinal. Revista Española de Medicina Nuclear e Imagen Molecular 2022;41:S44-S45. [DOI: 10.1016/j.remn.2021.06.005] [Reference Citation Analysis]
|
3 |
Barahona Z D, Chong M G, Sola A J. Lobular breast cancer bone metastases detected with 68Ga-DOTATATE PET/CT performed for intestinal neuroendocrine tumor. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021:S2253-8089(21)00136-1. [PMID: 34593349 DOI: 10.1016/j.remnie.2021.09.002] [Reference Citation Analysis]
|
4 |
Faast A, Ikeda DM, Pittman S, Demartini W, Kozlov A. FDG Avid Abnormalities in the Breast: Breast Cancer Mimics. Curr Radiol Rep 2021;9. [DOI: 10.1007/s40134-021-00383-5] [Reference Citation Analysis]
|
5 |
Guirguis MS, Adrada BE, Surasi DS, Dryden MJ. 68Ga-DOTATATE Uptake in Primary Breast Cancer. Clin Nucl Med 2021;46:248-9. [PMID: 33234932 DOI: 10.1097/RLU.0000000000003421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|